Contrave Available for Chronic Weight Management
Takeda and Orexigen announced that Contrave (naltrexone HCl and bupropion HCl) extended-release tablets are now available by prescription.
Takeda and Orexigen announced that Contrave (naltrexone HCl and bupropion HCl) extended-release tablets are now available by prescription.
Weight regain was about the same for people who lost weight gradually vs. quickly.
Family meals that are positive, calm and friendly may prevent childhood obesity.
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee has voted 14-1 in favor of approval of liraglutide for weight management in obese patients.
Compared with usual care, technology-assisted weight loss interventions in the primary care setting help patients achieve more weight loss.
The FDA has approved combination naltrexone and bupropion (Contrave) for weight management in obese adults or overweight adults with at least one weight-related comorbid condition.
Vagal nerve block therapy may be effective for weight loss in morbid obesity, and trends in bariatric surgery procedures have changed from 2006 to 2013.
For overweight and obese adults, significant weight loss is achieved with any low-carbohydrate or low-fat diet, with minimal between-diet differences.
A low-carbohydrate diet appeared to be more effective for weight loss and cardiovascular disease risk reduction.
Patients with Cushing’s syndrome who were administered oral mifepristone (Korlym) daily experienced significant, sustained weight loss over the years as they continued on the medication.